carvedilol has been researched along with Acute Confusional Senile Dementia in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol treatment produced a significant increase in basal synaptic transmission and LTP in TgCRND8 mice, as compared to their vehicle-treated slices, in which basal neuronal transmission and LTP decreased." | 1.36 | Carvedilol reestablishes long-term potentiation in a mouse model of Alzheimer's disease. ( Arrieta-Cruz, I; Pasinetti, GM; Pavlides, C; Wang, J, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bulic, B | 1 |
| Pickhardt, M | 1 |
| Mandelkow, E | 1 |
| Yao, J | 2 |
| Sun, B | 2 |
| Institoris, A | 1 |
| Zhan, X | 1 |
| Guo, W | 1 |
| Song, Z | 1 |
| Liu, Y | 1 |
| Hiess, F | 1 |
| Boyce, AKJ | 1 |
| Ni, M | 1 |
| Wang, R | 2 |
| Ter Keurs, H | 1 |
| Back, TG | 2 |
| Fill, M | 1 |
| Thompson, RJ | 1 |
| Turner, RW | 1 |
| Gordon, GR | 1 |
| Chen, SRW | 2 |
| Chen, AW | 1 |
| Estillore, JP | 1 |
| Arrieta-Cruz, I | 2 |
| Wang, J | 2 |
| Pavlides, C | 2 |
| Pasinetti, GM | 2 |
| Ono, K | 1 |
| Dickstein, DL | 1 |
| Zhao, W | 1 |
| Qian, X | 1 |
| Lamparello, A | 1 |
| Subnani, R | 1 |
| Ferruzzi, M | 1 |
| Ho, L | 1 |
| Hof, PR | 1 |
| Teplow, DB | 1 |
| Howlett, DR | 1 |
| George, AR | 1 |
| Owen, DE | 1 |
| Ward, RV | 1 |
| Markwell, RE | 1 |
1 review available for carvedilol and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Progress and developments in tau aggregation inhibitors for Alzheimer disease.
Topics: Alzheimer Disease; Animals; Clinical Trials as Topic; Humans; Hydrogen Bonding; Models, Molecular; P | 2013 |
5 other studies available for carvedilol and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Limiting RyR2 Open Time Prevents Alzheimer's Disease-Related Neuronal Hyperactivity and Memory Loss but Not β-Amyloid Accumulation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; CA1 Region, Hippocampal; Carvedilol; Dendritic Sp | 2020 |
Genetically and pharmacologically limiting RyR2 open time prevents neuronal hyperactivity of hippocampal CA1 neurons in brain slices of 5xFAD mice.
Topics: Alzheimer Disease; Animals; CA1 Region, Hippocampal; Carvedilol; Disease Models, Animal; Humans; Meg | 2021 |
Carvedilol reestablishes long-term potentiation in a mouse model of Alzheimer's disease.
Topics: Action Potentials; Adrenergic beta-Antagonists; Alzheimer Disease; Animals; Carbazoles; Carvedilol; | 2010 |
Carvedilol as a potential novel agent for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Brain; Carbazoles; Carvedilol; Disease Models, Animal; Female; Humans; M | 2011 |
Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Carbazoles; Carvedilol; Cell Survival; Daunorubicin; Human | 1999 |